The American College of Cardiology recently released recommendations indicating that inflammation should be considered when trying to predict heart disease.
In a report issued in the Journal of the American College of Cardiology on Sept. 29, the college said that the high-sensitivity C-reactive protein (hsCRP) blood test that measures CRP, a known inflammatory marker that increases in response to inflammation in the body, can determine whether a person is at risk of developing cardiovascular disease (CVD).
